Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Mol Genet Genomics ; 294(6): 1375-1383, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31214765

RESUMO

Forkhead box O (FoxO) is a downstream transcription factor of the insulin-signaling pathway, which plays vital roles in the growth and metabolism of organisms. In this study, BmFoxO was overexpressed in BmE cells, in which proliferation was inhibited and apoptosis was increased. The transgenic vector overexpressing BmFoxO was constructed, and the transgenic silkworm line A4FoxO was generated via embryonic microinjection. The body size of A4FoxO silkworm was smaller than that of non-transgenic silkworm (WT). The quantitative polymerase chain reaction results revealed that the insulin pathway was enhanced and the growth-related TOR pathway was suppressed. Furthermore, the translation of proteins in the fat body of A4FoxO silkworm was inhibited. The expression level of genes involved in the glucose synthesis and lipolysis pathways was increased, whereas that of genes involved in fat synthesis was decreased. Oil red O staining revealed that the amount of lipid droplets was reduced in A4FoxO silkworms compared with WT. Further analysis showed that the content of triglyceride and glycogen was significantly decreased in fat body, but the content of glucose and trehalose was increased in the hemolymph of A4FoxO silkworms. These results suggest that the enhanced expression of BmFoxO disturbs glycolipid metabolism and affects silkworm growth.


Assuntos
Bombyx/metabolismo , Fatores de Transcrição Forkhead/metabolismo , Glucose/biossíntese , Proteínas de Insetos/metabolismo , Lipólise , Animais , Animais Geneticamente Modificados/genética , Animais Geneticamente Modificados/metabolismo , Bombyx/embriologia , Bombyx/genética , Bombyx/crescimento & desenvolvimento , Linhagem Celular , Proliferação de Células , Corpo Adiposo/metabolismo , Fatores de Transcrição Forkhead/genética , Proteínas de Insetos/genética , Larva/crescimento & desenvolvimento , Metabolismo dos Lipídeos/genética , Lipólise/genética , Açúcares/metabolismo , Triglicerídeos/metabolismo
2.
Biol Res ; 50(1): 9, 2017 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-28249617

RESUMO

BACKGROUND: A number of dysregulated miRNAs have been identified and are proposed to have significant roles in the pathogenesis of type 2 diabetes mellitus or renal pathology. Alpinia oxyphylla has shown significant anti-inflammatory properties and play an anti-diabetes role. The objective of this study was to detect the alteration of miRNAs underlying the anti-diabetes effects of A. oxyphylla extract (AOE) in a type II diabetic animal model (C57BIKsj db-/db-). RESULTS: Treatment with AOE for 8 weeks led to lower concentrations of blood glucose, urine albumin, and urine creatinine. 17 and 13 miRNAs were statistically identified as differentially regulated in the DB/DB and db-/db- AOE mice, respectively, compared to the untreated db-/db- mice. Of these, 7 miRNAs were identified in both comparison groups, and these 7 miRNAs were verified by quantitative real-time PCR. Functional bioinformatics showed that the putative target genes of 7 miRNAs were associated with several diabetes effects and signaling pathways. CONCLUSIONS: These founding suggest that the potential of AOE as a medicinal anti-diabetes treatment through changes in the expressions of specific miRNAs. The results provide a useful resource for future investigation of the role of AOE-regulated miRNAs in diabetes mellitus.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/farmacologia , Rim/efeitos dos fármacos , MicroRNAs/efeitos dos fármacos , Extratos Vegetais/farmacologia , Albuminúria , Alpinia , Animais , Glicemia/análise , Creatinina/sangue , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Nefropatias Diabéticas/tratamento farmacológico , Nefropatias Diabéticas/metabolismo , Regulação da Expressão Gênica , Rim/metabolismo , Masculino , Camundongos Endogâmicos C57BL , MicroRNAs/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Reprodutibilidade dos Testes , Análise de Sequência de RNA , Fatores de Tempo , Resultado do Tratamento
3.
J Nanosci Nanotechnol ; 14(7): 5581-6, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24758069

RESUMO

This paper utilizes non-Fourier two-temperature heat conduction model to investigate the temperature field in nanometer-sized thin films irradiated by an ultrashort-pulse laser. Ultrashort-pulse laser processing for nanometer-sized devices is usually applied in MEMS and nanotechnology. For ultrashort-pulse laser interaction with metals, the two-temperature model was proposed to describe the heat transport in metals due to a substantial nonequilibrium between the electron and lattice temperature. For heat conduction in nanoscale devices, Fourier law is inadequate for describing the heat conduction in nanoscale due to the boundary scattering and the finite relaxation time of heat carriers. Therefore, in this work, the Non-Fourier two-temperature heat conduction model used to analyze ultrashort-pulse laser processing of nanoscale metal film. The result obtained from non-Fourier heat conduction equations is compared with the available experimental data. The parametric effects are also discussed.

4.
J Nanosci Nanotechnol ; 21(6): 3306-3311, 2021 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-34739786

RESUMO

Magnetic nanoparticles (MNPs) subjected to external alternating magnetic field can induce heat in MNPs due to hysteresis, which is usually employed for tumor hyperthermia. An effective hyperthermia treatment should selectively kill the tumor cells without damaging the ambient healthy tissue. Hence, it is important for hyperthermia to correctly control the alternating magnetic field-induced temperature of MNPs in the tumor. This work develops a thermal model to analyze various forms of temperature-rise with time in magnetic nanoparticles for tumor hyperthermia. Results show that there are horizontal, linear rise, square root, exponential decay and abrupt temperature-rise lines with time in MNPs. The horizontal, linear rise, and square root temperature lines with time are consistent with the available experimental data. It is worthily noted that the form of abrupt temperaturerise with time can result in harm to the normal cells or tissue. If the abrupt temperature-rise does not be controlled and predicted well.


Assuntos
Hipertermia Induzida , Nanopartículas de Magnetita , Nanopartículas , Anisotropia , Humanos , Hipertermia , Campos Magnéticos , Temperatura
5.
Biomolecules ; 9(8)2019 07 30.
Artigo em Inglês | MEDLINE | ID: mdl-31366115

RESUMO

In the silkworm, the sex-determination primary signal Fem controls sex differentiation by specific binding of Fem-derived piRNA to the cleavage site in Masc mRNA, thus inhibiting Masc protein production in the female. In this study, we identified a novel splicing isoform of Masc, named Masc-S, which lacks the intact sequence of the cleavage site, encoding a C-terminal truncated protein. Results of RT-PCR showed that Masc-S was expressed in both sexes. Over-expression of Masc-S and Masc in female-specific cell lines showed that Masc-S could be translated against the Fem-piRNA cut. By RNA-protein pull-down, LC/MS/MS, and EMSA, we identified a protein BmEXU that specifically binds to an exclusive RNA sequence in Masc compared to Masc-S. Knockdown of Masc-S resulted in abnormal morphology in female external genital and increased expression of the Hox gene Abd-B, which similarly occurred by Bmexu RNAi. These results suggest that the splice variant Masc-S against Fem-piRNA plays an important role in female external genital development, of which function is opposite to that of full-length Masc. Our study provides new insights into the regulatory mechanism of sex determination in the silkworm.


Assuntos
Bombyx/crescimento & desenvolvimento , Bombyx/genética , Genitália Feminina/crescimento & desenvolvimento , Proteínas de Insetos/genética , RNA Interferente Pequeno/genética , Animais , Sequência de Bases , Sítios de Ligação , Linhagem Celular , Feminino , Masculino , Isoformas de Proteínas/genética , Deleção de Sequência
6.
Biol. Res ; 50: 9, 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-838964

RESUMO

BACKGROUND: A number of dysregulated miRNAs have been identified and are proposed to have significant roles in the pathogenesis of type 2 diabetes mellitus or renal pathology. Alpinia oxyphylla has shown significant anti-inflammatory properties and play an anti-diabetes role. The objective of this study was to detect the alteration of miRNAs underlying the anti-diabetes effects of A. oxyphylla extract (AOE) in a type II diabetic animal model (C57BIKsj db-/db-). RESULTS: Treatment with AOE for 8 weeks led to lower concentrations of blood glucose, urine albumin, and urine creatinine. 17 and 13 miRNAs were statistically identified as differentially regulated in the DB/DB and db-/db- AOE mice, respectively, compared to the untreated db-/db- mice. Of these, 7 miRNAs were identified in both comparison groups, and these 7 miRNAs were verified by quantitative real-time PCR. Functional bioinformatics showed that the putative target genes of 7 miRNAs were associated with several diabetes effects and signaling pathways. CONCLUSIONS: These founding suggest that the potential of AOE as a medicinal anti-diabetes treatment through changes in the expressions of specific miRNAs. The results provide a useful resource for future investigation of the role of AOE-regulated miRNAs in diabetes mellitus.


Assuntos
Animais , Masculino , Camundongos , Extratos Vegetais/farmacologia , MicroRNAs/efeitos dos fármacos , Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/farmacologia , Rim/efeitos dos fármacos , Fatores de Tempo , Glicemia/análise , Regulação da Expressão Gênica , Reprodutibilidade dos Testes , Resultado do Tratamento , Análise de Sequência de RNA , Creatinina/sangue , MicroRNAs/metabolismo , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Nefropatias Diabéticas/metabolismo , Nefropatias Diabéticas/tratamento farmacológico , Albuminúria , Reação em Cadeia da Polimerase em Tempo Real , Rim/metabolismo , Camundongos Endogâmicos C57BL
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA